Clinicopathological features and treatment outcome of paediatric differentiated thyroid cancer treated with Radioactive Iodine-131 therapy in Hospital Kuala Lumpur, Malaysia

Background: Radioactive iodine 131I (RAI) therapy is one of the definitive treatments for paediatric differentiated thyroid cancer (DTC) initiated at nuclear medicine departments. In Malaysia, there is a need to identify the standardisation of treatment regimes to align with international standards....

Full description

Bibliographic Details
Main Authors: Khor, Phay Phay, Suppiah, Subapriya, Wong, Teck Huat, Amir Hassan, Siti Zarina
Format: Article
Published: Malaysian Medical Association 2021
Online Access:http://psasir.upm.edu.my/id/eprint/96407/
_version_ 1848862358525444096
author Khor, Phay Phay
Suppiah, Subapriya
Wong, Teck Huat
Amir Hassan, Siti Zarina
author_facet Khor, Phay Phay
Suppiah, Subapriya
Wong, Teck Huat
Amir Hassan, Siti Zarina
author_sort Khor, Phay Phay
building UPM Institutional Repository
collection Online Access
description Background: Radioactive iodine 131I (RAI) therapy is one of the definitive treatments for paediatric differentiated thyroid cancer (DTC) initiated at nuclear medicine departments. In Malaysia, there is a need to identify the standardisation of treatment regimes to align with international standards. We aimed to evaluate the clinicopathological features and the patient response to RAI therapy among paediatric DTC cases at Hospital Kuala Lumpur (HKL), Malaysia. Methods: A retrospective, longitudinal study was conducted among paediatric DTC patients treated with RAI in HKL and followed up between 2000-2016. Sixty-five patients were studied (mean period: 58.8±36 months). The clinicopathological data of the patients was recorded, and descriptive analysis was made. The association between categorical and continuous data with disease status was assessed using chi-square and Kruskal-Wallis tests, p-value <0.05 taken as statistically significant. Results: Most patients were female (78.5%), and adolescents comprised 89.2%. Pre-pubertal age, those presenting with cervical nodal involvement, extra-thyroidal extension and lymphovascular invasion were significantly associated with distant metastases at presentation. There was no mortality reported during the follow-up period. Sixty per cent of patients achieved remission, while 40% had persistent disease. The persistent disease was significantly correlated with distant metastasis at presentation (p=0.025). Conclusions: Paediatric DTC manifests with a more extensive disease burden at presentation and requires multiple RAI doses. Despite this, it carries an excellent overall prognosis.
first_indexed 2025-11-15T13:15:45Z
format Article
id upm-96407
institution Universiti Putra Malaysia
institution_category Local University
last_indexed 2025-11-15T13:15:45Z
publishDate 2021
publisher Malaysian Medical Association
recordtype eprints
repository_type Digital Repository
spelling upm-964072023-01-30T06:50:06Z http://psasir.upm.edu.my/id/eprint/96407/ Clinicopathological features and treatment outcome of paediatric differentiated thyroid cancer treated with Radioactive Iodine-131 therapy in Hospital Kuala Lumpur, Malaysia Khor, Phay Phay Suppiah, Subapriya Wong, Teck Huat Amir Hassan, Siti Zarina Background: Radioactive iodine 131I (RAI) therapy is one of the definitive treatments for paediatric differentiated thyroid cancer (DTC) initiated at nuclear medicine departments. In Malaysia, there is a need to identify the standardisation of treatment regimes to align with international standards. We aimed to evaluate the clinicopathological features and the patient response to RAI therapy among paediatric DTC cases at Hospital Kuala Lumpur (HKL), Malaysia. Methods: A retrospective, longitudinal study was conducted among paediatric DTC patients treated with RAI in HKL and followed up between 2000-2016. Sixty-five patients were studied (mean period: 58.8±36 months). The clinicopathological data of the patients was recorded, and descriptive analysis was made. The association between categorical and continuous data with disease status was assessed using chi-square and Kruskal-Wallis tests, p-value <0.05 taken as statistically significant. Results: Most patients were female (78.5%), and adolescents comprised 89.2%. Pre-pubertal age, those presenting with cervical nodal involvement, extra-thyroidal extension and lymphovascular invasion were significantly associated with distant metastases at presentation. There was no mortality reported during the follow-up period. Sixty per cent of patients achieved remission, while 40% had persistent disease. The persistent disease was significantly correlated with distant metastasis at presentation (p=0.025). Conclusions: Paediatric DTC manifests with a more extensive disease burden at presentation and requires multiple RAI doses. Despite this, it carries an excellent overall prognosis. Malaysian Medical Association 2021 Article PeerReviewed Khor, Phay Phay and Suppiah, Subapriya and Wong, Teck Huat and Amir Hassan, Siti Zarina (2021) Clinicopathological features and treatment outcome of paediatric differentiated thyroid cancer treated with Radioactive Iodine-131 therapy in Hospital Kuala Lumpur, Malaysia. Medical Journal of Malaysia, 76 (4). 510 - 517. ISSN 0300-5283 http://www.e-mjm.org/2021/v76n4
spellingShingle Khor, Phay Phay
Suppiah, Subapriya
Wong, Teck Huat
Amir Hassan, Siti Zarina
Clinicopathological features and treatment outcome of paediatric differentiated thyroid cancer treated with Radioactive Iodine-131 therapy in Hospital Kuala Lumpur, Malaysia
title Clinicopathological features and treatment outcome of paediatric differentiated thyroid cancer treated with Radioactive Iodine-131 therapy in Hospital Kuala Lumpur, Malaysia
title_full Clinicopathological features and treatment outcome of paediatric differentiated thyroid cancer treated with Radioactive Iodine-131 therapy in Hospital Kuala Lumpur, Malaysia
title_fullStr Clinicopathological features and treatment outcome of paediatric differentiated thyroid cancer treated with Radioactive Iodine-131 therapy in Hospital Kuala Lumpur, Malaysia
title_full_unstemmed Clinicopathological features and treatment outcome of paediatric differentiated thyroid cancer treated with Radioactive Iodine-131 therapy in Hospital Kuala Lumpur, Malaysia
title_short Clinicopathological features and treatment outcome of paediatric differentiated thyroid cancer treated with Radioactive Iodine-131 therapy in Hospital Kuala Lumpur, Malaysia
title_sort clinicopathological features and treatment outcome of paediatric differentiated thyroid cancer treated with radioactive iodine-131 therapy in hospital kuala lumpur, malaysia
url http://psasir.upm.edu.my/id/eprint/96407/
http://psasir.upm.edu.my/id/eprint/96407/